Explore more publications!

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on January 21, 2026

RadiantBiz Emerges as Top Company Helping Europeans Set Up Business in Dubai
Spire.AI and CrossKnowledge Announce Partnership to Redefine Enterprise Learning and Skills-based Talent Transformation
Open Hearts Foundation Sets Landmark Weekend Celebrating 2026 Healing Arts Gala and Founder Jane Seymour’s 75th Birthday
Raluca Niță Discusses Emerging Shifts in U.S.–Europe Security Expectations
Alice & Bob Develops ‘Elevator Codes’ to Slash Error Rates on Cat Qubit Quantum Computers
Idea Prototipi unveils the era of physical AI and the 'Action-Driven' industrial revolution
3UVIEW - China Best OEM Car Rear Window LED Display Manufacturer: Meeting CE & FCC Certification Standards
AXA and ICEYE strike ‘landmark’ deal to use ultra-high-quality SAR data to track extreme weather events
Following Major CES 2026 Success,  My Arcade Announces its Presence at European Showcase Spielwarenmesse in Nuremberg
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
AB Science obtient un brevet japonais pour l'utilisation du masitinib dans le traitement des formes progressives de la sclérose en plaques (SEP) jusqu'en 2041
OSE Immunotherapeutics salue l'octroi de la désignation de médicament orphelin par la FDA du pegrizprument (VEL-101)
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma
Le tribunal arbitral confirme la résiliation par Ipsen de l'accord de R&D conclu avec Galderma
Empower Her Journey: A Portland Community Celebration Supported by JELENEW

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions